Presentations

BioCardia Corporate Presentation

The Science of CardiAMP Cell Therapy

Presentation from the 2nd Annual Acute Respiratory Distress Syndrome Drug Development Symposium

Events

July 2022

Event: Late-Stage Advancements in Heart Failure Therapeutics and Management, presented by Maxim Group LLC and hosted by M-Vest

Date: July 14, 2022, 10:00AM ET

Location: Virtual conference - live on M-Vest

Subject:  A panel discussion on heart failure with several late-stage players in the space: BioCardia, Inc. (BCDA), Mesoblast Limited (MESO), Recardio Inc. (private), and scPharmaceuticals Inc. (SCPH)

Please click here to register for the event and to access BioCardia's presentation. 

--------------------

Event: 2nd Annual Acute Respiratory Distress Syndrome Drug Development Symposium

Date: July 15, 2022, 9:10AM ET

Location: Virtual conference 

Subject: Exploring the IV NK1R+ MSC in Acute Respiratory Distress Syndrome

Please click here to register for the event and to access BioCardia's presentation. 



News


Have questions?
CALL US NOW
: (800) 624-1179
Have questions?
EMAIL US NOW
: info@biocardia.com

biocardia takes a new and comprehensive
approach to heart failure

By introducing patient screening and highly-efficient delivery to stem cell therapy, the company seeks to increase the likelihood of treatment success, enabling more patients to return to the things they love.